Carbapenem-resistant Enterobacteriacae (CRE) is becoming an organism of concern in Ontario health care. PIDAC-IPC recently updated Annex A to provide additional guidance on the management of CRE. Public Health Ontario Laboratory and the Quality Management Proficiency Laboratory Services (QMP-LS) have provided guidance to Ontario laboratories for detection of CRE. A recent letter from the Chief Medical Officer of Health has also requested that Ontario laboratories participate in a voluntary surveillance program. This webinar will review the guidance for detection, identification and management of CRE in hospital settings as well as the components of the voluntary surveillance.
Dr. Samir Patel
Dr. Samir Patel is a clinical microbiologist at the PHO Laboratory. His clinical responsibilities include vector borne zoonotic diseases as well as reference antimicrobial susceptibility testing. His research interests include understanding and detecting antibiotic resistant organisms.
Dr. Susan Poutanen
Dr. Susan Poutanen received her Medical Degree from the University of Toronto in 1996 and completed Internal Medicine and Medical Microbiology Residencies at the University of Toronto and an Infectious Diseases Fellowship at Stanford University, California. She received her Masters of Public Health with a focus on Epidemiology from the University of California, Berkeley in 2002.
Dr. Poutanen is currently employed as a Medical Microbiologist and Infectious Diseases Physician at Mount Sinai Hospital & University Health Network in Toronto, Canada and an assistant professor in the Department of Laboratory Medicine and Pathobiology and Department of Medicine at the University of Toronto. Her broad research interests include the epidemiology and detection of antimicrobial resistance and the diagnosis of and preparedness for emerging and re-emerging infectious diseases such as carbapenemase-producing Enterobacteriaceae.
Camille Achonu is an epidemiologist with an extensive background in public health focusing on communicable diseases. At PHO, she specializes in hospital-acquired infections and works closely with Infectious Disease Prevention and Control team
Dr. Roberto Melano
Dr. Roberto Melano is a molecular microbiologist at the PHO Laboratory-Research. His lab is involved in the detection and characterization of resistance to different antibiotic families in both Gram-negative and -positive pathogens, as well as in the development of genetic and phenotypic tests applied to antimicrobial resistance diagnosis.
To discuss the guidelines for detection of CRE in the laboratory setting.
To review process for submission of isolates to PHO Laboratory.
To review the voluntary surveillance program for CRE.
Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA). If you require accommodations to participate in this event, please contact 647-260-7100 or email@example.com.